[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

Katsifis et al., 2007 - Google Patents

T lymphocytes in Sjögren's syndrome: contributors to and regulators of pathophysiology

Katsifis et al., 2007

View PDF
Document ID
16497588163489973019
Author
Katsifis G
Moutsopoulos N
Wahl S
Publication year
Publication venue
Clinical reviews in allergy & immunology

External Links

Snippet

Sjögren's syndrome is a chronic autoimmune disorder characterized by lymphocytic infiltration and malfunction of the exocrine glands, resulting in dry mouth and eyes. This multigenic and multifunctional disease can present as primary Sjögren's syndrome or …
Continue reading at www.academia.edu (PDF) (other versions)

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues ; Not used, see subgroups
    • C12N5/0602—Vertebrate cells
    • C12N5/0634—Cells from the blood or the immune system
    • C12N5/0636—T lymphocytes
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
    • G01N33/5047—Cells of the immune system
    • G01N33/505—Cells of the immune system involving T-cells
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2803—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
    • C07K16/2818—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily against CD28 or CD152
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution

Similar Documents

Publication Publication Date Title
Katsifis et al. T lymphocytes in Sjögren’s syndrome: contributors to and regulators of pathophysiology
Tian et al. The role of GITR/GITRL interaction in autoimmune diseases
Zitti et al. Natural killer cells in inflammation and autoimmunity
Pappu et al. TL1A–DR3 interaction regulates Th17 cell function and Th17-mediated autoimmune disease
Fife et al. Insulin-induced remission in new-onset NOD mice is maintained by the PD-1–PD-L1 pathway
Shi et al. Reciprocal regulation between natural killer cells and autoreactive T cells
Soroosh et al. Herpesvirus entry mediator (TNFRSF14) regulates the persistence of T helper memory cell populations
Batten et al. IL-27 supports germinal center function by enhancing IL-21 production and the function of T follicular helper cells
Jackson et al. B cell IFN-γ receptor signaling promotes autoimmune germinal centers via cell-intrinsic induction of BCL-6
Kennedy et al. Deciphering CD30 ligand biology and its role in humoral immunity
Cannons et al. SAP regulates T cell–mediated help for humoral immunity by a mechanism distinct from cytokine regulation
Spolski et al. Interleukin-21: basic biology and implications for cancer and autoimmunity
Axtell et al. CD5-CK2 binding/activation-deficient mice are resistant to experimental autoimmune encephalomyelitis: protection is associated with diminished populations of IL-17-expressing T cells in the central nervous system
Gao et al. Regulation of antigen‐expressing dendritic cells by double negative regulatory T cells
Lee et al. The influence of T cell Ig mucin-3 signaling on central nervous system autoimmune disease is determined by the effector function of the pathogenic T cells
Ikeda et al. Dual effects of TRAIL in suppression of autoimmunity: the inhibition of Th1 cells and the promotion of regulatory T cells
Ettinger et al. Pathogenic mechanisms of IgE-mediated inflammation in self-destructive autoimmune responses
Mora et al. Pancreatic infiltration but not diabetes occurs in the relative absence of MHC class II-restricted CD4 T cells: studies using NOD/CIITA-deficient mice
Whiteside et al. IL-10 deficiency reveals a role for TLR2-dependent bystander activation of T cells in Lyme arthritis
Sgouroudis et al. Impact of protective IL-2 allelic variants on CD4+ Foxp3+ regulatory T cell function in situ and resistance to autoimmune diabetes in NOD mice
Ruhmann et al. Endogenous activation of adaptive immunity: tenascin‐C drives interleukin‐17 synthesis in murine arthritic joint disease
Nabekura et al. Antigen-specific expansion and differentiation of natural killer cells by alloantigen stimulation
Singh et al. pConsensus peptide induces tolerogenic CD8+ T cells in lupus-prone (NZB× NZW) F1 mice by differentially regulating Foxp3 and PD1 molecules
Ding et al. Plasmacytoid dendritic cells regulate autoreactive B cell activation via soluble factors and in a cell-to-cell contact manner
Summers-deLuca et al. Expression of lymphotoxin-αβ on antigen-specific T cells is required for DC function